Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world's largest semiconductor designers and manufacturers, have begun the implementation of ...

Further confirmatory data will be necessary to maintain its approval in the US, where it will be co-marketed by EMD Serono, German Merck’s US biopharma business, and Pfizer. The drug was ...

Merck and Intel have launched a collaborative academic research initiative in Europe, bringing together eleven institutions ...

Thank you, Briana. Good afternoon, and welcome to Tempus’ third quarter 2024 conference call. This afternoon, Tempus released results for the quarter ending September 30, 2024. Joining me today from ...

TEM also announced a three-year extension with Merck EMD at the culmination of the last three-year strategic agreement. Per third-quarter fiscal 2024 press release, TEM announced that it has ...

Tempus AI, Inc. TEM reported third-quarter 2024 adjusted loss per share of 25 cents, which beat the Zacks Consensus Estimate ...

At the forthcoming Pharmaccess Leaders Forum Spring conference, Ana Céspedes, senior vice president of global marketing and strategy at EMD Serono, a business of Merck KGaA, Darmstadt ...

Kelly Hansbury, workforce planning project manager at EMD Electronics, said that EMD is part of Merck KGaA, Darmstadt, Germany, which operates in the sectors of electronics, health care and life ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Tempus AI, Inc. TEM reported third-quarter 2024 adjusted loss per share of 25 cents, which beat the Zacks Consensus Estimate of a loss of 27 cents per share by 7.4%. GAAP loss per share was 46 ...